March2 Alleviates Aortic Aneurysm/Dissection by Regulating PKM2 Polymerization

Abstract

Our findings demonstrated that March2 is a novel endogenous defender that prevents AAD by inhibiting vascular smooth muscle cell apoptosis, suggesting that March2 represents a potential therapeutic target for AAD.